Why HIV Screening Is Recommended Once for Almost Every Adult

The U.S. Preventive Services Task Force gives HIV screening its highest mark, a grade A recommendation, for everyone ages 15 to 65, which means a clinician should offer the test once as part of routine care rather than waiting for a patient to appear high risk. That recommendation rests on two findings that are no longer in serious dispute: treating HIV early substantially lowers a person's own risk of severe illness and death, and a person on effective treatment whose virus is undetectable does not pass HIV to sexual partners. Because testing only the people who seem high risk leaves too many infections undiscovered, a single universal test, offered on an opt-out basis, finds diagnoses that risk questions alone never reach.

What the recommendation actually says

The Task Force finalized this grade A statement in 2019. It calls for one-time screening of all adolescents and adults from 15 to 65, screening of younger teens and older adults who have increased risk, and screening of every pregnant person, including during labor if their status is unknown. The recommended mechanism is opt-out testing, meaning the test is a default step in care that a patient can decline after being informed, rather than something a clinician must argue for case by case.

On how often to retest, the Task Force was candid: it found insufficient evidence to set an optimal interval, so the firm recommendation is at least one test for the general population, with repeat testing reserved for people who have ongoing exposure. The Centers for Disease Control and Prevention frames its clinical guidance the same way, advising that everyone from 13 to 64 be tested at least once as a routine matter and that people with continuing risk be tested at least once a year.

Why once for almost everyone instead of only the high risk

Risk-based testing sounds efficient, but it depends on two fragile steps: a clinician has to ask about sexual behavior and drug use, and a patient has to disclose accurately. Both fail often, in busy visits, across language and cultural distance, and wherever stigma makes honesty costly. The result is that a meaningful share of people living with HIV in the United States do not know they carry it, by CDC estimates, and many of them have had contact with the health system without ever being offered a test.

Universal opt-out screening is designed to route around that failure. By making the test routine and unremarkable, it lowers the stigma that suppresses both asking and disclosing, and it catches infections that a targeted approach would miss entirely. That is the reason the grade A recommendation covers the general adult population rather than a narrowly defined subgroup.

The benefit to the person tested

Early diagnosis matters because early treatment works. The large randomized START trial, published in 2015, compared starting antiretroviral therapy immediately against waiting until the immune system had declined, and found that immediate treatment substantially lowered the risk of serious AIDS-related and non-AIDS-related events. Diagnosing HIV before it does damage is what allows treatment to turn a once-fatal infection into a manageable chronic condition, and a test is the only way to reach that starting line.

The benefit to everyone else

The second finding is about transmission. The HPTN 052 study followed couples in which one partner had HIV and one did not, and found that starting treatment early to suppress the virus reduced sexual transmission of HIV by more than 90 percent. That trial anchored the treatment-as-prevention evidence that the CDC now summarizes with the phrase undetectable equals untransmittable: a person who takes HIV medication and keeps a durably undetectable viral load does not transmit the virus to sexual partners. Treatment, in other words, is also prevention, and diagnosis is the door that has to open before either benefit is possible.

What grade A means, and what it does not

A grade A rating is not a slogan. It signals that the Task Force has high certainty the screening delivers substantial net benefit for the covered population. It also carries a practical consequence in the United States: under the Affordable Care Act, grade A and B preventive services are generally covered by insurers without cost-sharing, so a routine HIV test usually reaches the patient without a copay.

What the recommendation is not is individual medical advice. It is a population-level judgment about what to offer nearly everyone, and personal decisions about testing frequency and risk belong in a conversation with a qualified clinician. This article is educational and not a substitute for that advice.

Reading the word almost

The one-time frame is a floor, not a ceiling. The word almost in "almost every adult" does real work: people with continuing exposure need repeat testing, often yearly, and pregnancy is its own universal indication regardless of prior tests. A single lifetime screen is the minimum the evidence supports for the general population, and the recommendation is deliberately built so that a one-time test never becomes a reason to skip a needed second one.